We are studying whether adding pembrolizumab to standard chemotherapy and radiation helps patients with advanced laryngeal cancer avoid laryngectomy. This trial also examines the impact on swallowing quality and overall survival.
Health conditions and diseases that the clinical trial is designed to study and treat.
Advanced Laryngeal and Hypopharyngeal Cancer refers to aggressive forms of cancer in the throat that may require total laryngectomy for treatment. This condition is characterized by the presence of squamous cell carcinoma (SCC) in advanced stages, often requiring specific biomarker testing for treatment eligibility.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.